-
, such as with PET, MR, and optical imaging. Ability to characterize and test agents including in animal models is advantageous. The candidate will work independently and will be responsible for literature
-
construction, and gene expression in vitro and in vivo is needed. Expertise in stem cells and immune cells is desirable. Familiarity with FACS is desirable. Ability to characterize and test these including in
-
cells (hiPSCs). The Hong laboratory has identified small molecules that enhance cardiac performance in human IPSC-derived cardiomyocytes (iPSC-CMs). The first goal is to examine the mechanism of action
-
pluripotent stem cells (hiPSCs). Primary responsibility is to utilize the CRISPR/Cas9 genomic engineering technology to examine the impact of genomic ablation of the candidate target genes on iPSC-CM and animal
-
an international reputation for genetically engineering and testing vaccines against a wide variety of enteric and other infections, including malaria, COVID-19 and influenza. Based in the School of Medicine
-
, epigenetics, biochemistry, cell biology, developmental biology, and bioinformatics to study the molecular mechanism of disease, identify / validate disease causing genetic variants, and test potential
-
contractility in the regulation of blood flow in development and disease models. The focus is on the myosin phosphatase (MP), a critical target of signals that regulate blood flow. Experiments will test the
-
contractility in the regulation of blood flow in development and disease models. The focus is on the myosin phosphatase (MP), a critical target of signals that regulate blood flow. Experiments will test the